Mark Jeffrey DeLong
APLSMark Jeffrey DeLong serves as officer: Chief Business & Strat Officer at Apellis Pharmaceuticals, Inc. (APLS). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.
Mark Jeffrey DeLong's Insider Trading at Apellis Pharmaceuticals, Inc. (APLS)
Buys
0 · $0.00
Sells
34 · $4.81M
Total Shares Bought
0
Total Shares Sold
93,448
Related Insiders
David O. Watson
officer: General Counsel
APLSSell · Jan 23, 2026
James George Chopas
VP/Chief Accounting Officer
APLSSell · Jan 23, 2026
Pascal Deschatelets
officer: Chief Scientific Officer
APLSSell · Jan 23, 2026
Caroline Baumal
officer: Chief Medical Officer
APLSSell · Jan 23, 2026
Cedric Francois
director, officer: Chief Executive Officer
APLSSell · Jan 23, 2026
Nur Nicholson
officer: Chief Technical Officer
APLSSell · Jan 23, 2026
Timothy Eugene Sullivan
officer: Chief Financial Officer
APLSSell · Jan 23, 2026
Dunlop A. Sinclair
Director
APLSSell · Sep 30, 2025